Cited by 174Nutrition and Health in AgingPancreatic and Hepatic Oncology ResearchMuscle Physiology and Disorders

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review

Open access

Ozola Zalite, I., Zykus, R., Francisco Gonzalez, M., Saygili, F., Pukitis, A., Gaujoux, S., Charnley, R.M., Lyadov, V.·2015·Pancreatology

DOI 10.1016/j.pan.2014.11.006

Open this paper in CoChat — free account

Abstract

Background/objectives Cachexia affects ∼ 80% of pancreatic cancer patients. An international consensus defines cachexia as an ongoing loss of skeletal muscle mass (sarcopenia) with or without loss of fat, which impairs body functioning and cannot be reversed by conventional nutritional measures. Weight loss percentage and elevated inflammation markers have been employed to define this condition earlier. This review aimed to assess the prevalence and consequences of cachexia and sarcopenia on survival in patients with pancreatic ductal adenocarcinoma. Methods The systematic review was performed by searching the articles with preset terms published in PubMed and Cochrane Database until December 2013. After identifying relevant titles, abstracts were read and eligible articles data retrieved on preformatted sheets. The prevalence and impact of sarcopenia/cachexia on survival was evaluated. Results In total 1145 articles were retrieved, only 10 were eligible. Definitions of cachexia and sarcopenia were heterogeneous. In patients with normal weight (BMI 18.5-24.9 kg/m(2)) the prevalence of sarcopenia ranged from 29.7 to 65%. In overweight or obese patients (BMI >25 kg/m(2)) were 16.2%-67%. Sarcopenia alone was not demonstrated to be an independent factor of decreased survival, although obese sarcopenic patients were shown to have significantly worse survival in two studies. Conclusions Impact of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma is currently understudied in the available literature. Definitive association between cachexia and survival cannot be drawn from available studies, although weight loss and sarcopenic obesity might be considered as poor prognostic factors. Further prospective trials utilizing the consensus definition of cachexia and including other confounding factors are needed to investigate the impact of cachexia and sarcopenia on survival in pancreatic adenocarcinoma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pan.2014.11.006

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 6,020
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition Study
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R. A., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,761
Prognostic effect of weight loss prior tochemotherapy in cancer patients
DeWys, W. D., Begg, C. B., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,350
Cachexia: a new definition.
Evans, W., Morley, J., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,341
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K. S., Mackey, J. R., Koski, S. L., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,125
Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women
Delmonico, M. J., Harris, T. B., Lee, J., Visser, M., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Newman, A. B., & for the Health, A. A. B. C. S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01140.x · Cited by 819
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.
Fearon, K., Voss, A., & Hustead, D. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1345 · Cited by 739

Flagged first, then by citations

Show all 34 references

Sorted by citations

Items 101–174 of 174

Influence of sarcopenia on postoperative complications and long-term survival in pancreatic cancer patients undergone pancreaticoduodenectomy
Qu, G., Zhou, C., Zhang, Y., Lyu, S., & Lang, R. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1434630 · Cited by 10
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
Kiriukova, M. A., de la Iglesia, D., Panić, N., Bozhychko, M., Avci, B., Maisonneuve, P., de‐Madaria, E., Capurso, G., & Şandru, V. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00495 · Cited by 10
Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
Mortier, V., Wei, F., Pellat, A., Marchèse, U., Dohan, A. J. J., Brézault, C., Barat, M., Fuks, D., Soyer, P. A., & Coriat, R. (2022) · Cancers · doi:10.3390/cancers14246179 · Cited by 10
Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy
Tsukagoshi, M., Harimoto, N., Araki, K., Kubo, N., Watanabe, A., Igarashi, T., Ishii, N., Yamanaka, T., Hagiwara, K., Hoshino, K., et al. (2021) · Cancers · doi:10.3390/cancers13164105 · Cited by 10
Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer
Gunesch, A. N., Sutton, T. L., Krasnow, S. M., Deig, C. R., Sheppard, B. C., Marks, D. L., & Grossberg, A. J. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.03.025 · Cited by 9
The effect of a chemotherapy drug cocktail on myotube morphology, myofibrillar protein abundance, and substrate availability
Mora, S., & Adegoke, O. A. J. (2021) · Physiological Reports · doi:10.14814/phy2.14927 · Cited by 9
P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy
Lazzari, N. D., Götte, M., Kasper, S., Meier, E., Schüler, M., Pogorzelski, M., Siveke, J. T., & Tewes, M. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08650-9 · Cited by 11
Prognostic impact of preoperative cachexia in patients undergoing major hepatopancreatobiliary surgery for malignancy
Fugane, Y., Tanaka, S., Mizuno, Y., Nakajima, H., Yamamoto, H., Inoue, T., Nagaya, M., Nishida, Y., Onoe, S., Yamaguchi, J., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.02.014 · Cited by 8
Unveiling hidden outcomes in malignant gastric outlet obstruction research – insights from a "Pancreas 2000" review
Boas, F. V., Rizzo, G. E. M., de Ponthaud, C., Robinson, S. M., Gaujoux, S., Capurso, G., Vanella, G., & Bozkirli, B. O. (2024) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v16.i8.451 · Cited by 8
Self-citation
Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab‑paclitaxel: A retrospective study
Tozuka, Y., Ueno, M., Kobayashi, S., Morimoto, M., Fukushima, T., Sano, Y., Kawano, K., Hanaoka, A., Tezuka, S., Asama, H., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13495 · Cited by 8
Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial
Luo, H., Galvao, D. A., Newton, R. U., Tang, C., Dean, A. P., Jasas, K., Johansson, M., Yusoff, I. F., Spry, N. A., & Taaffe, D. R. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000642 · Cited by 8
Prevalence and outcome of sarcopenia in patients with inflammatory bowel disease: a follow-up study
Dharap, V., Desai, D., Abraham, P., Gupta, T., Dhoble, P., Mehta, N., & Modhe, J. (2025) · Intestinal Research · doi:10.5217/ir.2024.00096 · Cited by 7
Sarcopenia—A New Frontier in the Management Care of Patients With Borderline Resectable Pancreatic Cancer
Griffin, O. M., & Conlon, K. C. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.1006 · Cited by 7
Pylorus‐preserving versus Pylorus‐resecting : Impact on dynamic changes of nutrition and body composition in pancreatic cancer patients before and after pancreatoduodenectomy
Jin, Q., Ren, Q., Chang, X., Lu, X., Wang, G., & He, N. (2022) · Cancer Medicine · doi:10.1002/cam4.5155 · Cited by 7
Paradigm shift for defining the resectability of pancreatic cancer
Kang, M., & Kim, S.-W. (2021) · Annals of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/ahbps.2021.25.4.451 · Cited by 6
Preoperative Rapid Weight Loss as a Prognostic Predictor After Surgical Resection for Pancreatic Cancer
Nishikawa, M., Yamamoto, J., Einama, T., Hoshikawa, M., Iwasaki, T., Nakazawa, A., Takihara, Y., Tsunenari, T., & Kishi, Y. (2022) · Pancreas · doi:10.1097/mpa.0000000000002186 · Cited by 6
Association of Weight Change, Inflammation Markers and Disease Staging with Survival of Patients Undergoing Chemotherapy for Pancreatic Adenocarcinoma
de Matos, L. V., Coelho, A., Cunha, R., Fernandes, L., Sousa, M. F. E., Neves, M. T., Cardoso, D. S. D. A., Malheiro, M., Graça, J., Silva, E. S., et al. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1903049 · Cited by 6
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview
Tarasiuk, A., Mirocha, G., & Fichna, J. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01146-4 · Cited by 6
Bridging clinic: The initial medical management of patients with newly diagnosed pancreatic cancer
Sreedharan, L., Kumar, B., Jewell, A., Banim, P. J. R., Koulouris, A. I., & Hart, A. R. (2018) · Frontline Gastroenterology · doi:10.1136/flgastro-2018-101002 · Cited by 6
Skeletal muscle is independently associated with grade 3–4 toxicity in advanced stage pancreatic ductal adenocarcinoma patients receiving chemotherapy
Aberle, M. R., Coolsen, M. M. E., Wenmaekers, G., Volmer, L., Brecheisen, R., van Dijk, D. P. J., Wee, L., van Dam, R. M., de Vos‐Geelen, J., Rensen, S. S., et al. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.11.004 · Cited by 5
Effects of parenteral nutrition + best supportive nutritional care vs. best supportive nutritional care alone on quality of life in patients with pancreatic cancer—a secondary analysis of PANUSCO
Emanuel, A., Rosenberger, F., Krampitz, J., Decker-Baumann, C., Märten, A., Jäger, D., & Rötzer, I. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08666-1 · Cited by 5
The impact of immunonutrition on pancreaticoduodenectomy outcomes
Wang, X., Littau, M. J., Fahmy, J. N., Kisch, S., Varsanik, M. A., O'Hara, A., Pozin, J. J., Knab, L. M., & Abood, G. J. (2022) · Surgery in Practice and Science · doi:10.1016/j.sipas.2022.100106 · Cited by 5
Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?
Cefalì, M., Scala, I., Pavone, G., Helbling, D., Hussung, S., Fritsch, R., Reiner, C. S., Stocker, S., Koeberle, D., Kissling, M., et al. (2023) · Cancers · doi:10.3390/cancers15174398 · Cited by 5
Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics
Davis, M. P., Bader, N., Basting, J., Vanenkevort, E. A., Koppenhaver, N., Patel, A. A., Gupta, M., Lagerman, B., & Wojtowicz, M. J. (2024) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2024.10.004 · Cited by 5
Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial
Encabo, P. G., Gardiner, J. R., Norris, M. K., Wilson, R. L., Normann, A. J., Nguyen, D., Parker, N. H., Tjogas, D., Brais, L. K., Meyerhardt, J. A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322192 · Cited by 5
Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer
Köstek, O., Demircan, N. C., Gökyer, A., Küçükarda, A., Sunal, B. S., Hacıoğlu, M. B., Eslame, H., Solak, S., Yılmaz, E., Uzunoğlu, S., et al. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02079-x · Cited by 5
Nutrition Intake and Nutrition Status of Pancreatic Cancer Patients: Cross-Sectional and Longitudinal Analysis of a Randomized Controlled Exercise Intervention Study
Clauss, D., Rötzer, I., Tjaden, C., Hackert, T., Wiskemann, J., & Steindorf, K. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2077382 · Cited by 5
Bibliometric analysis of research trends in relationship between sarcopenia and surgery
Liu, T., Song, F., Su, D., & Tian, X.-F. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2022.1056732 · Cited by 5
Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with a Poor Performance Status
Takeda, T., Sasaki, T., Okamoto, T., Fukuda, K., Hirai, T., Yamada, M., Nakagawa, H., Mie, T., Furukawa, T., Kasuga, A., et al. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3577-24 · Cited by 4
Unexpected Side Effects of a High S-1 Dose: Subanalysis of a Phase III Trial Comparing Gemcitabine, S-1 and Combinatorial Treatments for Advanced Pancreatic Cancer
Kobayashi, S., Ueno, M., Hara, H., Irie, K., Goda, Y., Moriya, S., Tezuka, S., Tanaka, M., Okusaka, T., Ohkawa, S., et al. (2016) · Oncology · doi:10.1159/000446989 · Cited by 4
Effectiveness of the nutrition referral system in a multidisciplinary pancreatic cancer clinic
Wong, S., Reddy, A. V., Hacker‐Prietz, A., Kress, L., Pathak, P., Hill, C., Lin, T. A., Herman, J. M., He, J. P., Zheng, L., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07795-3 · Cited by 4
Supplemental tube feeding: qualitative study of patient perspectives in advanced pancreatic cancer
Nguyen, G., Furness, K., Croagh, D. G., Haines, T. P., & Hanna, L. (2024) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2024-004836 · Cited by 4
Medical oncology and pancreatic cancer: what the radiologist needs to know
Fogelman, D. R., & Varadhachary, G. A. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1432-9 · Cited by 3
Plasma desacyl ghrelin‑to‑acyl ghrelin ratio is a predictor of postoperative complications and prognosis after pancreaticoduodenectomy
Nishida, T., Tsubouchi, H., Hamada, T., İmamura, N., Hiyoshi, M., Yano, K., Kangawa, K., Nakazato, M., & Nanashima, A. (2019) · Oncology Letters · doi:10.3892/ol.2019.10821 · Cited by 3
Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival
Guan, R., Guo, W., Hong, W., Lin, Y., Zou, X., Shi, N., Yang, D., Zhou, Y., Jian, Z., Jin, H., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01031 · Cited by 3
Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer: A Case Report Demonstrating Significant Weight Gain and Quality of Life Improvement
Kan, M., Ogane, Y., Watabe, K., Takahashi, T., Sakai, M., Sekine, Y., Yamada, N., Sugihara, C., Ouchi, M., Nagashima, H., et al. (2025) · Internal Medicine · doi:10.2169/internalmedicine.4708-24 · Cited by 2
Psoas Muscle Volume Is a Useful Predictor of Postoperative Outcome in Elderly Patients With Non‐Small Cell Lung Cancer
Takashima, S., Matsuo, T., Kuriyama, S., Iwai, H., Suzuki, H., Fujibayashi, T., Shibano, S., Sato, Y., Nomura, K., Minamiya, Y., et al. (2025) · Thoracic Cancer · doi:10.1111/1759-7714.70077 · Cited by 2
Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer
Nofal, Y. H., Dail, Y. A., Assaf, Y., Samra, H. A., Abbas, F., Hamzeh, A., & Hasan, N. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012952 · Cited by 2
Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis
Karneris, A., Dedeilia, A., & Boland, G. M. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14395-2 · Cited by 2
Advancing the Understanding and Treatment of Cancer Cachexia: Mechanisms, Therapeutic Approaches, and Future Opportunities
Li, X., Xu, T., Zhou, L., Li, G., Yuan, Y., Song, H., Liu, C. X., & Liu, X. (2025) · Cancer Management and Research · doi:10.2147/cmar.s555236 · Cited by 1
A patient-mediated strategy to improve nutrition care after transition from hospital to home for pancreatic cancer surgery: a pilot randomised controlled trial study protocol
Turner, K. L., Milano, J., Santiago, C., Coutinho, J., Sprow, O., Hume, E., Nardella, N., Tabriz, A. A., Islam, J. Y., & Hodul, P. J. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113207 · Cited by 1
Patient‐derived pancreatic tumour organoid implantation establishes novel pre‐cachexia mouse models
Aberle, M. R., Vaes, R. D. W., van de Worp, W. R. P. H., Dubois, L. J., Lieuwes, N. G., Biemans, R., LANGEN, R. C. J., van Schooten, F., van Dam, R. M., Damink, S. W. M. O., et al. (2022) · JCSM Rapid Communications · doi:10.1002/rco2.71 · Cited by 1
Recovery Pattern of the Nutritional Status after Surgical Treatment for Pancreatic Head Disease: Compared with Malignancy and Non-malignancy
Kim, E., Han, Y., Kim, H., Kwon, W., Kim, S., & Jang, J. (2018) · Surgical Metabolism and Nutrition · doi:10.18858/smn.2018.9.2.51 · Cited by 1
Pankreaskarzinom − Bedeutung der Ernährung
AG Prävention und integrative Onkologie (AG PRIO), D. K., Reudelsterz, C., Hübner, J., & Erickson, N. T. (2019) · Der Onkologe · doi:10.1007/s00761-019-0583-4 · Cited by 1
Prehabilitation for Pancreatic Cancer Surgery
Hughes, M., & Lassen, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_37 · Cited by 1
Management of Advanced Pancreatic Cancer in Daily Clinical Practice
Giuliani, J., Piacentini, P., & Bonetti, A. V. (2015) · Tumori Journal · doi:10.5301/tj.5000428
Comprehensive Approach to Sarcopenia and Cachexia Treatment
Wakabayashi, H., & Sakuma, K. (2017) · Springer eBooks · doi:10.1007/978-981-10-3292-9_7
Distinct cachexia phenotypes and the importance of adipose tissue loss on survival of patients with advanced pancreatic cancer on FOLFIRINOX chemotherapy
Kays, J. K. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2772
Cancer Cachexia in Pancreatic Cancer Patients: Recent Advances and New Therapeutic Approach
Lee, S. H., & Chung, M. J. (2015) · Journal of Digestive Cancer Research
Medical Nutrition Therapy Throughout the Continuum of Care for Localized Pancreatic Cancers
Sonntag, K. (2019) · Springer eBooks · doi:10.1007/978-3-319-98944-0_14
Gezielte Ernährung beim Pankreaskarzinom — auf keinen Fall vernachlässigen!
Schorn, S., Friess, H., & Martignoni, M. (2019) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-019-6748-x
Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
Klunichenko, A. A., Seryakov, A. P., Seryakova, A. A., & Демидов, С. М. (2020) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2020-30-3-49-54
Nutritional Support and Therapy Before and After Pancreatic Surgery
Gianotti, L. V., Sandini, M., & Hackert, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_42
Exercise Treatment in Pancreatic Cancer
Lyadov, V. K., & Lyadov, K. V. (2021) · Pancreas · doi:10.1097/mpa.0000000000001773
Self-citation
Management of Pain in Pancreatic Cancer
Domínguez‐Muñoz, J. E. (2021) · doi:10.1002/9781119570097.ch62
The Effect of a Chemotherapy Drug Cocktail on Myotube Morphology and Protein Metabolism
Mora, S. (2019) · YorkSpace (York University)
Nutritional status disorders and methods of their correction in patients with advanced pancreatic cancer
Kiryukova, M. A., Dubtsova, E. A., Винокурова, Л. В., Malykh, M. V., & Bordin, D. S. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-195-11-66-74
Prehabilitation for Hepatobiliary-Pancreatic Cancer Surgery
Ann, S. M., Bonney, G. K., & Ashokka, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-6494-6_11
Identifikation und Prävention von Mangelernährung bei TumorpatientInnen
Erickson, N. T., Schmidt, L., & Mathies, V. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_339-1
En kvinne i 40-årene med cancer pancreas og vedvarende diaré
Bergheim, L. L., & Seferowicz, M. (2016) · Norsk tidsskrift for ernæring · doi:10.18261/ntfe.14.2.5
Prognostic Value Of PET/CT Determined Sarcopenia in Patients with Resected Ampullary Carcinoma
Başoğlu, T. (2022) · Eurasian Journal of Medical Investigation · doi:10.14744/ejmi.2023.28845
Beim Pankreaskarzinom gezielte Ernährung auf keinen Fall vernachlässigen
Schorn, S., Friess, H., & Martignoni, M. (2023) · Gastro-News · doi:10.1007/s15036-023-3206-2
Nutritional Considerations Prior to Surgery
Griffin, O. M. (2023) · doi:10.1002/9781119809128.ch3
Effects of parenteral nutrition vs. best supportive nutritional care on quality of life in patients with pancreatic cancer – A secondary analysis of PANUSCOPreprint
Emanuel, A., Rosenberger, F., Krampitz, J., Decker-Baumann, C., Märtens, A., Jäger, D., & Rötzer, I. (2024) · Research Square · doi:10.21203/rs.3.rs-3872282/v1
Deepening oxidative stress in pancreatic cancer due to malnutrition
Vávrová, L., Staňková, B., Rychlíková, J., & Žák, A. (2018) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2018.022
Current Status and Influencing Factors of Postoperative Sarcopenia in Pancreatic Cancer Patients
Zhang, L., Huang, Z., Tian, Q., Chen, Z., Zhao, J., Dong, Z., Zhang, M., & Chen, L. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18415-1
Additional file 1 of Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study
Kim, I.-H., Choi, M. H., Lee, I. S., Hong, T. H., & Lee, M. A. (2021) · Figshare · doi:10.6084/m9.figshare.13605524
Additional file 1 of Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
Shin, D. W., Kim, M. A., Lee, J.-C., Kim, J., & Hwang, J.-H. (2021) · Figshare · doi:10.6084/m9.figshare.14992859
Sex-specific prognostic value of triceps skinfold thickness and albumin in pancreatic cancer
Cho, Y. H., Ah, S. H., Kim, K., Chang, J.-I., Kim, H., Jang, D. K., Lee, S.-H., Lee, J. K., Lee, K. T., Lee, K. H., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115290
Prognostic stratification of unresectable locally advanced pancreatic cancer using a combination of inflammatory and nutritional indices: a retrospective cohort study
Matsumoto, M., Tsunematsu, M., Furukawa, K., Haruki, K., Shirai, Y., Uwagawa, T., Gocho, T., Onda, S., Yanagaki, M., & Ikegami, T. (2026) · Surgery Today · doi:10.1007/s00595-026-03344-7
Exploring patient perspectives of exercise in advanced pancreatic cancer care in Canada: A qualitative interpretive description
Cyr, C., Perry, B., Ramjeesingh, R., Blanchard, C., & Keats, M. R. (2026) · Palliative & Supportive Care · doi:10.1017/s1478951526103356
Drastic muscle wasting following surgery is a strong predictor of prognosis in early-stage pancreatic cancer–a Taiwanese multicenter cohort study
Chen, C.-Y., Hou, Y.-C., Chao, Y.-J., Kan, N.-N., Wang, M.-H., Liu, Y.-W., Lin, Y.-H., Chih-Jung, W., Huang, C.-J., Chiu, T.-J., et al. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101468
The Neoadjuvant Window: Serial Assessment of Sarcopenia During Treatment for Pancreatic Cancer
Cheung, D. C., Deshpande, A. J., Wasif, N., Butterfield, R. J., Korfiatis, P. D., Klug, J. R., Sandrasegaran, K., Fong, Z. V., & Stucky, C. (2026) · The American Surgeon · doi:10.1177/00031348261495994
Skeletal Muscle Index, Tumor and Systemic Immunity, and Survival in Advanced Pancreatic Ductal Adenocarcinoma
Ma, Y., Jia, R., Fan, M., Deng, G., Liu, T., Wang, Y., Li, Y., Zhang, N., Pang, F., Shi, Y., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.72378

Authors: Ozola Zalite, I., Zykus, R., Francisco Gonzalez, M., Saygili, F., Pukitis, A., Gaujoux, S., Charnley, R. M., & Lyadov, V.
Affiliations: Lithuanian University of Health Sciences (LT)
Sorbonne Paris Cité (FR)
Freeman Hospital (GB)
Ministry of Health of the Russian Federation (RU)
Corresponding author: Lyadov, V.
ORCID: Zykus, R.
Gaujoux, S.
Charnley, R.M.
Lyadov, V.
Venue: Pancreatology
Publisher: Elsevier BV
Published: 2015-01
Volume: 15
Issue: 1
Pages: 19-24
ISSN: 1424-3903 (ISSN-L)
DOI: 10.1016/j.pan.2014.11.006
OpenAlex: W2068101666
Cited by: 174
References: 34
Citations by year: 2026: 7 · 2025: 7 · 2024: 15 · 2023: 13 · 2022: 25 · 2021: 25 · 2020: 14 · 2019: 22 · 2018: 17 · 2017: 10 · 2016: 13 · 2015: 6
FWCI: 1.13
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pancreatology (publishedVersion)
PubMed (publishedVersion)
Lithuanian University of Health Sciences (submittedVersion)
RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Newcastle University ePrints (Newcastle Univesity)
Funders: Educational and Research Program Pancreas 2000
Topics: Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords: cachexia, sarcopenia, pancreatic ductal adenocarcinoma, survival, skeletal muscle mass, sarcopenic obesity, weight loss, obesity, prognostic factors, inflammatory markers
MeSH terms: Cachexia, Humans, Pancreatic Neoplasms, Prognosis, Weight Loss, Prevalence, Survival Rate, Carcinoma, Pancreatic Ductal, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks